The pills have eyes
Amazon has led healthcare on a wild scavenger hunt the past year and last week revealed the “treasure." With scant detail, they announced a partnership with JPMorgan and Berkshire Hathaway in an effort to lower healthcare costs for 1M Americans—their employees. They wouldn’t be the first employer consortium to try to lower health costs. The announcement rippled across airwaves, erased $30B in market value in two hours, and worried many JPMorgan clients.
Headlines
The Pills Have Eyes
Tweet | Pacific Standard
Amazon Wants To Disrupt Healthcare in US. In China, Tech Giants Already Have.
Tweet | The New York Times
The Digital Health Future Is Not Here. Yet: The Trough Of Disillusionment
Tweet | KQED
Steve Kraus On Why Apple Can Succeed In Building A Personal Health Record
Tweet | CNBC
Is Pay For Performance A Dangerous Health Policy Fad That Won't Die?
Tweet | STAT
Democratizing Clinical Trials
Tweet | Wired
Judge Dismisses Opternative's Suit Against South Carolina Eye Care Law
Tweet | MobiHealthNews
Rock Health in the News
Omada Health To Launch Largest Clinical Trial Of Digital DPP
Tweet | MobiHealthNews
Fitbit, Apple, Startups Explore Blood-Sugar Tracking For Diet, Health (Sano)
Tweet | Business Insider
Recent Funding
- Halo Neuroscience collected $13M for its brain-stimulating headset
- To accelerate drug discovery with genomics/AI, Engine Biosciences raised $10M
- The startup that wants you to wear VR headsets during workouts, VirZOOM, raised $5.5M
- Diligent Robotics closed $2.1M to help hospital workers with busywork